Resilience to Establish a Biomanufacturing Partnership with AstraZeneca and Purchase AstraZeneca’s Manufacturing Site in West Chester, Ohio

URLhttps://www.businesswire.com/news/home/20221129005
SourceBusinesswire
Date Published11/29/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name National Resilience Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2023
City reshored to:West Chester
State(s) reshored to:OH
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredmedicines
What non-domestic negative factors made offshoring less attractive?Supply chain interruption risk/Natural disaster risk/Political instability
What domestic positive factors made reshoring more attractive?Eco-system synergies, Skilled workforce availability/training, Under-utilized capacity
Find Reshoring Articles